Einat Brill Almon, SVP, Product Development at Protalix BioTherapeutics, Inc. (PLX), sold 166,848 shares at $7.13 ($1.2M) on 2012-05-02, disclosed to the SEC on 2012-05-04.
Scheduled sale ($1.2M) by SVP, Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PLX | SELL | 2009-10-19 | $847K | — | Filing → |
| PLX | SELL | 2009-07-08 | $280K | — | Filing → |
| PLX | SELL | 2009-05-19 | $160K | — | Filing → |